Michael E. Nassif
Impact in
-
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
-
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 50
- Cardiomyopathy and Myosin Studies 26
- Cardiac Valve Diseases and Treatments 2
-
- Mechanical Circulatory Support Devices 30
- Co-authors
- Mikhail Kosiborod (33 shared papers)Shane LaRue (26 shared papers)John A. Spertus (25 shared papers)Eric L. Novak (17 shared papers)Justin M. Vader (18 shared papers)David S. Raymer (12 shared papers)Suzanne V. Arnold (10 shared papers)Phil G. Jones (11 shared papers)
- Journals
- Journal of Cardiac Failure (18 papers)JACC Heart Failure (17 papers)Journal of the American College of Cardiology (12 papers)European Journal of Heart Failure (10 papers)The American Journal of Cardiology (7 papers)
- Partner nations
- United StatesAustraliaPoland
In The Last Decade
Michael E. Nassif
118 papers receiving 4.8k citations
Michael E. Nassif's Hit Papers
Peers
Comparison fields: 5 of 92
- Cardiology and Cardiovascular Medicine 3k
- Endocrinology, Diabetes and Metabolism 1.1k
- Biomedical Engineering 641
- Geriatrics and Gerontology 57
- Nephrology 117
Countries citing papers authored by Michael E. Nassif
This map shows the geographic impact of Michael E. Nassif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Nassif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Nassif more than expected).
Fields of papers citing papers by Michael E. Nassif
This network shows the impact of papers produced by Michael E. Nassif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Nassif. The network helps show where Michael E. Nassif may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Nassif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Hit paper breakdown → | 2022 | 679 |
| 2 | The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial Hit paper breakdown → | 2021 | 464 |
| 3 | Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction Hit paper breakdown → | 2019 | 343 |
| 4 | Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure Hit paper breakdown → | 2021 | 214 |
| 5 | 2021 | 193 | |
| 6 | The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial Hit paper breakdown → | 2022 | 190 |
| 7 | Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Hit paper breakdown → | 2024 | 187 |
| 8 | Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial Hit paper breakdown → | 2022 | 168 |
| 9 | 2017 | 165 | |
| 10 | 2022 | 113 | |
| 11 | 2018 | 91 | |
| 12 | 2016 | 81 | |
| 13 | 2022 | 77 | |
| 14 | 2016 | 75 | |
| 15 | 2021 | 75 | |
| 16 | 2014 | 74 | |
| 17 | 2021 | 73 | |
| 18 | 2015 | 72 | |
| 19 | 2023 | 71 | |
| 20 | 2016 | 68 |
About Michael E. Nassif
Michael E. Nassif is a scholar working on Cardiology and Cardiovascular Medicine, Biomedical Engineering, Endocrinology, Diabetes and Metabolism, Surgery and Public Health, Environmental and Occupational Health, having authored 126 papers that have together received 5k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (50 papers), Mechanical Circulatory Support Devices (30 papers), Cardiomyopathy and Myosin Studies (26 papers), Diabetes Treatment and Management (12 papers), Transplantation: Methods and Outcomes (3 papers), Telemedicine and Telehealth Implementation (2 papers), Cardiac Valve Diseases and Treatments (2 papers) and Potassium and Related Disorders (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3k citations), Endocrinology, Diabetes and Metabolism (1.1k citations), Biomedical Engineering (641 citations), Geriatrics and Gerontology (57 citations) and Nephrology (117 citations). Michael E. Nassif has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Mikhail Kosiborod, Shane LaRue, John A. Spertus, Eric L. Novak, Justin M. Vader, David S. Raymer, Suzanne V. Arnold, Phil G. Jones, Javed Butler and Scott C. Silvestry. Their work appears in journals such as Journal of Cardiac Failure, JACC Heart Failure, Journal of the American College of Cardiology, European Journal of Heart Failure and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.